Send to a Friend Share

Pfizer (PFE) Agrees To Acquire Wyeth (WYE) In $68 Billion Cash-and-Stock Deal

January 26, 2009 6:55 AM EST
Pfizer (NYSE: PFE) agreed to acquire Wyeth (NYSE: WYE) in a cash-and-stock transaction currently valued at $50.19 per share, or a total of approximately $68 billion.

Under the terms of the transaction, each outstanding share of Wyeth common stock will be converted into the right to receive $33 in cash and 0.985 of a share of Pfizer common stock, subject to the terms of the merger agreement. Based on the closing price of Pfizer stock as of January 23, 2009, the stock component is valued at $17.19 per share.

The transaction will be financed through a combination of cash, debt and stock. A consortium of banks has provided commitments for a total of $22.5 billion in debt.

In connection with the proposed transaction between Pfizer and Wyeth, the Board of Directors of Pfizer has determined that, effective with the dividend to be paid in the second quarter of 2009, it will reduce Pfizer's quarterly dividend per share to $0.16.

You May Also Be Interested In


Related Categories

Dividends, Hot List, Mergers and Acquisitions

Related Entities

Dividend

Add Your Comment





Follow StreetInsider.com On Twitter